Trial intelligence / Profile preview

S-8184 Paclitaxel in Relapsed Stage IIIB/IV NSCLC

NCT00034164Phase 2Completed

Sponsor
Achieve Life Sciences
Start
Apr 2002
Primary completion
Sep 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of paclitaxel in non-small cell lung cancer (NSCLC), sponsored by Achieve Life Sciences. Started Apr 2002; status: completed.

02

Drugs

paclitaxel
03

Conditions

non-small cell lung cancer (NSCLC)

Beyond the preview

Go deeper on NCT00034164.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00034164.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call